Author:
Fariman Soroush,Momeni Nasab Fatemeh,Faraji Hoda,Afzali Monireh
Funder
Iran University of Medical Sciences
Alborz University of Medical Sciences
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference61 articles.
1. Current and future treatment strategies in chronic lymphocytic leukemia;Patel;J Hematol Oncol,2021
2. Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study;Ou;Front Oncol,2022
3. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL;Hallek;Blood,2018
4. Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia;Burger;N Engl J Med,2015
5. Evolution of CLL treatment—from chemoimmunotherapy to targeted and individualized therapy;Burger;Nat Rev Clin Oncol,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献